AzTrials
AzTrials

Orthodontic RetainersNCT07098325

Biological Reaction of Direct 3d Printed Retainers

A study testing retainer with .5 mm thickness and retainer with 1 mm thickness in people with Orthodontic Retainers, run by Al-Azhar University at 1 site in Egypt.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The aim of this study will be to evaluate the biological reaction of direct three dimensional printed retainers. Primary objective is to evaluate bacterial growth and color stability between different thicknesses of 3d printed material used as a retainer . Read more about this study

Who is it for?
Any age
Conditions the study is for
Orthodontic Retainers
What is being tested?
retainer with .5 mm thickness and retainer with 1 mm thickness
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
26 participants
Where
1 siteEgypt
Study dates
1 Oct 2025to 1 Jun 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • -Finished fixed orthodontic therapy and seeking for retention as a part of their original treatment plan.
  • Good oral hygiene.
  • No habits (e.g., smoking)

Who cannot join

  • Medication affecting saliva.
  • intrinsic tooth discoloration.
  • Uncooperative patients.
  • Patient with periodontitis.
  • Learning difficulties and inability to read written instructions.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Norhan Ibrahim Eldsokee Master's Candidate, B.D.S contact

+20 01559921144

noureldsokee@gmail.com

Egypt1 site, 1 recruiting
  • Faculty of Dental Medicine , Al-Azhar University

    Asyut

    Recruiting

Other trials in Egypt

About this study

Official title: Evaluation of Biological Reaction of Direct Three Dimensional Printed Retainers

The aim of this study will be to evaluate the biological reaction of direct three dimensional printed retainers.

Primary objective is to evaluate bacterial growth and color stability between different thicknesses of 3d printed material used as a retainer .

Secondary objective is to determine the optimal thickness for use in clear aligner fabrication based on biological performance.

Read the detailed description

Retainers are routinely fitted at the end of active orthodontic treatment to allow the teeth to adjust to their new positions The growing demand has led to constant improvements in materials and technologies offered by a rising number of different companies.

In recent years, major technological innovations in 3D printing, especially related to computer-aided design, biomaterials and manufacturing techniques, have enabled the production of in-office direct printed Retainers (DPRs) - representing an innovation compared to the traditional thermoformed Retainers.

Insufficient cleaning will lead to microbe's growth in retainers. The mostly found microbes are candida and staphylococcus that may include MRSA strains. Once the biofilms are formed in the retainer it's quite difficult to remove that biofilm which shows resistance to antimicrobials and difficult to clear.

orthodontic retainers hinder the sterilizing effect of saliva, which further promotes the rapid division, reproduction, and growth of colonized bacteria.

Staphylococcus aureus is most commonly found on the retainers and tends to cause bloodstream infections which can lead to serious other infections.

While several studies have assessed tooth movement, and biomechanical and clinical effects according to the design of attachments, studies investigating the thickness of the CAs are limited

Being tested
retainer with .5 mm thickness, retainer with 1 mm thickness
Keywords
Different thicknesses, Direct three dimensional printed retainers, Bacterial growth, Color change

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • retainer with .5 mm thicknessDevice

    direct 3d printed retainer with .5 mm thickness

  • retainer with 1 mm thicknessDevice

    direct 3d printed retainer with 1 mm thickness,

Study groups in NCT07098325
Study groupRoleWhat they receive
direct 3d printed retainer of .5mmExperimentalgroup wearing direct 3d retainer of .5 mm
Receives: Device: retainer with .5 mm thickness
direct 3d printed retainer of 1mmExperimentalgroup wearing direct 3 d retainer with thickness 1 mm
Receives: Device: retainer with 1 mm thickness

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Bacterial growth measured using colony-forming unit (CFU) count on agar plates.

    Saliva samples will be collected from each participant at baseline and at day 14. Samples will be cultured on standard agar plates under aerobic conditions. After incubation, bacterial colonies will be counted, and results will be expressed in colony-forming units per milliliter (CFU/ml). A higher CFU value indicates greater bacterial growth.

    Units:

    CFU/ml

    Measured: from day 0 (Baseline time ) to 14 days after insertion

  2. Color change of 3D printed retainers measured using spectrophotometer; ΔE calculated at day 0 and day 14.

    The color stability of the retainers will be assessed using a spectrophotometer (VITA Easyshade or equivalent). Color difference (ΔE) will be calculated between baseline and day 14. A ΔE > 3.3 is considered clinically perceptible. Scale range: 0-10; higher ΔE score indicates greater color change and worse color stability.

    Units:

    ΔE (Delta E) score

    Measured: from day 0 (baseline time ) to 14 days after insertion

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Aug 2025
  2. Study start1 Oct 2025 (estimated)
  3. Primary completion1 Apr 2027 (estimated)
  4. Study completion1 Jun 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
26 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07098325
Sponsor's protocol ID
Direct 3d printed retainers
Status last verified
Jul 2025
First submitted
8 Jul 2025
Last updated
1 Aug 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing retainer with .5 mm thickness and retainer with 1 mm thickness in people with Orthodontic Retainers, run by Al-Azhar University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 1 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Norhan Ibrahim Eldsokee Master's Candidate, B.D.S (+20 01559921144, noureldsokee@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Bacterial growth measured using colony-forming unit (CFU) count on agar plates. (time frame: from day 0 (Baseline time ) to 14 days after insertion). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Aug 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in